Is Ardent Health Partners, Inc. (ARDT) overvalued? · P/E 8.5, rev $5.97B
Ardent Health Partners, Inc. (ARDT) is a medical care facilities company listed on US.
This page asks whether Ardent Health Partners, Inc. (ARDT) looks expensive on cached numbers — not a short thesis.
Latest reported ARDT revenue for 2024-12-31 was $5.97B. Net income was $299.7M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ARDT currently screens at market cap $2.10B and trailing P/E 8.5.
ARDT currently screens at market cap $2.10B and trailing P/E 8.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ARDT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ARDT stock page for the full model, not this heading.
Not investment advice.